Stipple Bio Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $100M

  • Investors
  • 10

Stipple Bio General Information

Description

Operator of a biotechnology company intended to unlock cellular profiling and target discovery. The company offers epitope-level resolution technology for single-cell profiling and allows the identification of novel therapeutic targets and the development of precision therapies, enabling users with therapies for a wide range of solid and hematologic malignancies.

Contact Information

Website
www.stipple.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 238 Main Street
  • Cambridge, MA 02142
  • United States
+1 (509)
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 238 Main Street
  • Cambridge, MA 02142
  • United States
+1 (509)

Stipple Bio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Stipple Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 31-Mar-2026 $100M Completed Pre-Clinical Trials
2. Seed Round 20-Dec-2024 Completed Pre-Clinical Trials
1. Seed Round 03-Jun-2022 $12M $12M Completed Pre-Clinical Trials
To view Stipple Bio’s complete valuation and funding history, request access »

Stipple Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed-1
Seed 1,200,000 $0.000100 6% $10 $10 1x $10 1.41%
To view Stipple Bio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Stipple Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Stipple Bio Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
GordonMD Global Investments PE/Buyout Minority
GV Corporate Venture Capital Minority
Lola Capital Partners Venture Capital Minority
Nextech Invest Venture Capital Minority
RA Capital Management Asset Manager Minority
You’re viewing 5 of 10 investors. Get the full list »

Stipple Bio Acquisitions (1)

Stipple Bio’s most recent deal was a Merger/Acquisition with Spotlight Therapeutics.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Spotlight Therapeutics Merger/Acquisition Biotechnology
To view Stipple Bio’s complete acquisitions history, request access »

Stipple Bio FAQs

  • When was Stipple Bio founded?

    Stipple Bio was founded in 2022.

  • Where is Stipple Bio headquartered?

    Stipple Bio is headquartered in Cambridge, MA.

  • What is the size of Stipple Bio?

    Stipple Bio has 9 total employees.

  • What industry is Stipple Bio in?

    Stipple Bio’s primary industry is Biotechnology.

  • Is Stipple Bio a private or public company?

    Stipple Bio is a Private company.

  • What is the current valuation of Stipple Bio?

    The current valuation of Stipple Bio is .

  • What is Stipple Bio’s current revenue?

    The current revenue for Stipple Bio is .

  • How much funding has Stipple Bio raised over time?

    Stipple Bio has raised $121M.

  • Who are Stipple Bio’s investors?

    GordonMD Global Investments, GV, Lola Capital Partners, Nextech Invest, and RA Capital Management are 5 of 10 investors who have invested in Stipple Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process